Characteristics of doripenem: a new broad-spectrum antibiotic.

Drug Design, Development and Therapy
Francisco Alvarez-LermaOlivia Ferrández

Abstract

Doripenem (S-4661) is a new parenteral antibiotic from the carbapenem class; similarly to imipenem and meropenem, it has a broad-spectrum activity against Gram-positive, Gram-negative, and anaerobic bacteria. It is active against multiresistant Gram-negative bacilli such as extended-spectrum beta-lactamase-producing (ESBL) Gram-negative Enterobacteriaceae and nonfermentative Gram-negative bacilli including some strains of Pseudomonas aeruginosa that are resistant to other carbapenems. Doripenem's chemical structure is similar to that of meropenem (substitution of one sulfamoxil-aminomethyl chain for the dimethyl-carboxyl chain), and has one 1-beta-methyl chain which provides resistance to dehydropeptidase-I enzyme. The clinical trials conducted so far have focused on the treatment of severe infections such as complicated intra-abdominal infections, complicated urinary tract infections and pyelonephritis, nosocomial pneumonia, and ventilator-associated pneumonia. Given its activity profile and the results from the clinical trials, this antibiotic may be used for empirical treatment of multibacterial infections produced by potentially multiresistant Gram-negative bacilli. In 2007, the US Food and Drug Administration approved the ...Continue Reading

References

May 1, 1996·The Journal of Antimicrobial Chemotherapy·M MoriS Mitsuhashi
Nov 18, 2000·Antimicrobial Agents and Chemotherapy·N MasudaT Nishino
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S A McConnellP O Gubbins
Feb 4, 2003·The Journal of Antimicrobial Chemotherapy·Masakatsu TsujiShuichi Miyazaki
Mar 30, 2004·Antimicrobial Agents and Chemotherapy·Yigong GeJames A Karlowsky
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·William A PrescottRandolph E Regal
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Ronald N JonesDouglas J Biedenbach
Sep 4, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yoshitsugu NakajimaToshiro Yamaguchi
Oct 16, 2004·The Journal of Antimicrobial Chemotherapy·Manica SodhiRaja Shekar
May 6, 2005·The Journal of Antimicrobial Chemotherapy·Steven D Brown, Maria M Traczewski
Aug 30, 2005·Antimicrobial Agents and Chemotherapy·Sujata M BhavnaniPaul G Ambrose
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Hannah M WexlerCalida Li
Nov 1, 2005·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yoshio Kobayashi
Nov 26, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T R FritscheR N Jones
May 27, 2006·Diagnostic Microbiology and Infectious Disease·Holly K HuynhRonald N Jones
Aug 31, 2006·Antimicrobial Agents and Chemotherapy·Lilian PumbweHannah M Wexler
Jan 9, 2007·International Journal of Antimicrobial Agents·Yoshikazu IshiiKeizo Yamaguchi
May 10, 2007·Drugs·George G ZhanelJames A Karlowsky
Aug 21, 2007·Journal of Pharmaceutical Sciences·Takayuki KatsubeYoshitaka Yano
Sep 22, 2007·The Journal of Antimicrobial Chemotherapy·Kazuro IkawaTaijiro Sueda
Oct 17, 2007·Antimicrobial Agents and Chemotherapy·Kim L CreditoPeter C Appelbaum
Feb 6, 2008·Antimicrobial Agents and Chemotherapy·Todd A DaviesRobert K Flamm
Mar 5, 2008·Journal of Pharmaceutical Sciences·Takayuki KatsubeMikihisa Takano
Apr 2, 2008·Critical Care Medicine·David Gilbert
May 7, 2008·Antimicrobial Agents and Chemotherapy·Aryun KimDavid P Nicolau
Jun 17, 2008·Critical Care : the Official Journal of the Critical Care Forum·Robert C Owens
Jun 25, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Matthew K BrammerDaniel Schaufelberger
Jul 23, 2008·Antimicrobial Agents and Chemotherapy·Iolanda CirilloKenneth Turner
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·David M LivermoreUNKNOWN BSAC Working Parties on Resistance Surveillance
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·David M LivermoreUNKNOWN BSAC Working Parties on Resistance Surveillance

❮ Previous
Next ❯

Citations

Jan 19, 2016·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kazuhiro YateraHiroshi Mukae
Feb 26, 2013·Journal of Chemotherapy·Dominique BreilhEmmanuel Boselli
Mar 23, 2017·European Journal of Medicinal Chemistry·Mohammed I El-GamalAmany Bahaaeldin
Jan 13, 2011·The Journal of Antibiotics·Shunkichi TanakaHiroaki Shirahase
Oct 2, 2020·European Journal of Medicinal Chemistry·Lidia Moreira LimaEliezer J Barreiro
Sep 14, 2012·Annals of Clinical Microbiology and Antimicrobials·Piyatip KhuntayapornMullika Traidej Chomnawang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Expert Review of Anti-infective Therapy
Harakh V Dedhia, Richard McKnight
Clinical Therapeutics
S James Matthews, Jason W Lancaster
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
John F Mohr
© 2022 Meta ULC. All rights reserved